Welcome to ZisNews!

Read your favorite news, except the excluded topics, by you. Register
No overlapping ads for registered users

US CDC advisers weigh lower age recommendation for RSV vaccines

Posted on: Apr 16, 2025 20:05 IST | Posted by: Hindustantimes
US CDC advisers weigh lower age recommendation for RSV vaccines

apr 16 - The U.S. Centers for Disease verify and Prevention's vaccinum experts ar expected to voter turnout on expanding access to respiratory syncytial virus shots in the second round of their meeting on Wednesday.

Guidelines from the Advisory Committee on Immunization Practices help physicians decide what vaccines to recommend to patients and are also used for determining insurance coverage in the U.S.

The country's health regulator has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's Abrysvo.

RSV typically causes cold-like symptoms, but is also a leading cause of pneumonia in toddlers and older adults. An estimated 15,000–20,000 annual RSV-associated hospitalizations occur in the U.S. In adults aged 50–59 years, according to the CDC.

The panel was initially due to meet in February but the meeting was delayed just days after Robert F. Kennedy Jr., a long-time vaccine skeptic, became the head of the U.S. Department of Health and Human Services. The session was postponed to allow for public comment, the HHS had said.

The experts are due to vote later on Wednesday on whether to recommend a single dose of RSV vaccines to adults aged 50 to 59 years who are at an increased risk of the severe disease. The CDC currently recommends the vaccine for adults 75 years and older and at-risk adults aged 60 to 74 years.

The CDC had decided to hold off on recommending RSV shots for adults under age 60 last year.

GSK's Arexvy and Pfizer's Abrysvo are approved for the prevention of lower respiratory tract disease caused by RSV in adults aged 50 to 59 and 18 to 59, respectively, who are at an increased risk of the disease. Moderna's application for at-risk adults aged 18 to 59 years is under review by the U.S. Food and Drug Administration.

The panel will also vote on recommendations for use of chikungunya, a mosquito-borne disease, and meningococcal vaccines.

On Tuesday, it discussed narrowing recommendations on the use of COVID-19 booster shots for the upcoming immunization campaign.

This article was generated from an automated news agency feed without modifications to text.

Global News Perspectives

In today's interconnected world, staying informed about global events is more important than ever. ZisNews provides news coverage from multiple countries, allowing you to compare how different regions report on the same stories. This unique approach helps you gain a broader and more balanced understanding of international affairs. Whether it's politics, business, technology, or cultural trends, ZisNews ensures that you get a well-rounded perspective rather than a one-sided view. Expand your knowledge and see how global narratives unfold from different angles.

Customizable News Feed

At ZisNews, we understand that not every news story interests everyone. That's why we offer a customizable news feed, allowing you to control what you see. By adding keywords, you can filter out unwanted news, blocking articles that contain specific words in their titles or descriptions. This feature enables you to create a personalized experience where you only receive content that aligns with your interests. Register today to take full advantage of this functionality and enjoy a distraction-free news feed.

Like or Comment on News

Stay engaged with the news by interacting with stories that matter to you. Like or dislike articles based on your opinion, and share your thoughts in the comments section. Join discussions, see what others are saying, and be a part of an informed community that values meaningful conversations.

Download the Android App

For a seamless news experience, download the ZisNews Android app. Get instant notifications based on your selected categories and stay updated on breaking news. The app also allows you to block unwanted news, ensuring that you only receive content that aligns with your preferences. Stay connected anytime, anywhere.

Diverse News Categories

With ZisNews, you can explore a wide range of topics, ensuring that you never miss important developments. From Technology and Science to Sports, Politics, and Entertainment, we bring you the latest updates from the world's most trusted sources. Whether you are interested in groundbreaking scientific discoveries, tech innovations, or major sports events, our platform keeps you updated in real-time. Our carefully curated news selection helps you stay ahead, providing accurate and relevant stories tailored to diverse interests.

Login to Like (0) Login to Dislike (0)

Login to comment.

No comments yet.